Prof. Dr. MURAT TUNCEL

Yayın Ağı

Makaleler 109

1. Validation of sentinel lymph node biopsy with completion neck dissection in oral cavity cancer

Pamuk A. E., Tellioğlu B., Eroğlu E., Kuşcu O., Süslü N., Tuncel M., et al.

ACTA OTO-LARYNGOLOGICA , cilt.1, sa.1, ss.1-6, 2025 (SCI-Expanded, Scopus)

2. The Randomized, Phase 2 Trial LuCAP Study.

Tuncel M., Kaya G., Kodaz O., Türkan C., Çağlar Tuncalı M.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , cilt.66, sa.6, ss.984-985, 2025 (SCI-Expanded, Scopus)

3. Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients

Busch F., Hoffmann L., Xu L., Zhang L. J., Hu B., Garcia-Juarez I., et al.

JAMA NETWORK OPEN , cilt.8, sa.6, 2025 (SCI-Expanded, Scopus)

4. Five-year follow-up of Estimabl 2 trail: a critical appraisal

TUNCEL M., Ovcaricek P. P., Giovanella L.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2025 (SCI-Expanded, Scopus)

5. ⁶⁸Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives

Urso L., Napolitano R., Speltri G., TUNCEL M., Badrane I., Uccelli L., et al.

CANCERS , sa.9, 2025 (SCI-Expanded, Scopus)

6. Relationship between HE4 levels and metabolic parameters in PET of non-small cell lung cancer patients

Yilmaz Y., Ozercan M. M., Ancin B., DİKMEN Z. G., ÇAĞLAR TUNCALI M., TUNCEL M., et al.

BIOMARKERS IN MEDICINE , sa.7, ss.259-265, 2025 (SCI-Expanded, Scopus)

7. Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence-A Systematic Review and Meta-Analysis

Hoffmann M. A., SOYDAL Ç., Virgolini I., TUNCEL M., Kairemo K., Kapp D. S., et al.

CANCERS , sa.5, 2025 (SCI-Expanded, Scopus)

8. Significant response to [²²⁵Ac]Ac-DOTATATE therapy in a patient with small cell lung cancer

TUNCEL M., Turkan C., Eryilmaz Y., Pala A., Kilickap S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , 2025 (SCI-Expanded, Scopus)

9. Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?

Ovcaricek P. P., de Keizer B., Campenni A., Kreissl M. C., Deandreis D., TUNCEL M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , sa.2, ss.380-385, 2025 (SCI-Expanded, Scopus)

10. Redifferentiation Therapies in Thyroid Oncology: Molecular and Clinical Aspects

Ovcaricek P. P., TUNCEL M., Aghaee A., Campenni A., Giovanella L.

JOURNAL OF CLINICAL MEDICINE , cilt.13, sa.23, 2024 (SCI-Expanded, Scopus)

11. Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer: a decision tree analysis in a European multicenter series

Giovanella L., Milan L., Roll W., Weber M., Schenke S., Kreissl M., et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE , cilt.62, ss.2307-2315, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer

AKYILDIZ A., Ismayilov R., Abdurrahimli N., Ormanci A., GÜVEN D. C., TUNCEL M., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , sa.2, ss.100-105, 2024 (SCI-Expanded, Scopus)

13. Plasmacytoma and Amyloid Lymphadenopathy, FDG, and Fluorocholine.

Kaya G., Akin S., Tuncel M., Kiratli P.

Clinical nuclear medicine , cilt.49, ss.559-560, 2024 (SCI-Expanded, Scopus)

14. The European Association of Nuclear Medicine (EANM)’s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?

Kreissl M. C., Ovčariček P. P., Campenni A., Vrachimis A., TUNCEL M., Giovanella L.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.51, sa.6, ss.1678-1681, 2024 (SCI-Expanded, Scopus)

15. P-20 Primary hyperparathyroidism associated with maltoma of the thyroid gland: imaging challenges

Erturk B., Kaya G., Tuncel M., Ergin M. I., Haznedaroglu I. C., Uner A., et al.

JCEM Case Reports , cilt.2, sa.Supplement_1, ss.13-14, 2024 (Hakemli Dergi)

16. Integrated Diagnostics of Thyroid Nodules

Giovanella L., Campennì A., Tuncel M., Petranović Ovčariček P.

CANCERS , cilt.16, sa.2, ss.311-322, 2024 (SCI-Expanded, Scopus)

17. Theranostics of Thyroid Cancer

Giovanella L., TUNCEL M., Aghaee A., Campenni A., Petranović Ovčariček P., De Virgilio A.

Seminars in Nuclear Medicine , 2024 (SCI-Expanded, Scopus)

18. Bilgisayarlı Tomografi, Pozitron Emisyon Tomografisi ve Nükleer Manyetik Rezonans Görüntülemede Temel Kavram ve İlkeler.

BAYARI S. H., AKIN S., TUNCEL M.

Batı Karadeniz Tıp Degisi , cilt.7, sa.3, ss.269-278, 2023 (TRDizin)

19. Unexpected Axillary Lymph Node Uptake During Lower-Limb Lymphoscintigraphy in a Case With Vulvar Lymphangioma Circumscriptum

SOYDAŞ TURAN B., TUNCEL M.

Clinical nuclear medicine , cilt.48, sa.10, ss.879-880, 2023 (SCI-Expanded, Scopus)

20. Molecular Pathological Markers and TERT Promoter Mutations: Correlations with Clinicopathological Features and Distant Metastasis in Turkish Patients with Papillary Thyroid Carcinoma

YILMAZ E., Güler G., KURTULAN O., Karakaya J., TELLİ T., TUNCEL M., et al.

Endocrinology Research and Practice , cilt.27, sa.4, ss.191-198, 2023 (Scopus, TRDizin)

21. Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

von Eyben R., Hoffmann M. A., SOYDAL Ç., Virgolini I., TUNCEL M., Gauthé M., et al.

Biomedicines , cilt.11, sa.9, 2023 (SCI-Expanded, Scopus)

22. Evaluation of efficacy of tumor-specific nanoliposomal radiosensitizer in radiotherapy

Karabuga M., ERDOĞAN S., Filikci K., Hazıroglu R., TUNCEL M., CENGİZ M.

Journal of Drug Delivery Science and Technology , cilt.86, 2023 (SCI-Expanded, Scopus)

23. Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer.

Petranović Ovčariček P., Campenni A., de Keizer B., Deandreis D., Kreissl M. C., Vrachimis A., et al.

Cancers , cilt.15, sa.17, 2023 (SCI-Expanded, Scopus)

24. Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer.

Giovanella L., Milan L., Roll W., Weber M., Schenke S., Kreissl M., et al.

European journal of nuclear medicine and molecular imaging , cilt.50, sa.9, ss.2767-2774, 2023 (SCI-Expanded, Scopus)

25. Value of Dynamic (18)F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study.

Kupik O., Tuncel M., Özgen Kıratlı P., Akpınar M. G., Altundağ K., Başaran Demirkazık F., et al.

Molecular imaging and radionuclide therapy , cilt.32, sa.2, ss.94-102, 2023 (Scopus, TRDizin)

26. Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with Lu-177-PSMA-617. A single-center prospective observational study

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., et al.

PROSTATE , cilt.83, sa.8, ss.792-800, 2023 (SCI-Expanded, Scopus)

27. Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with (177) Lu-PSMA-617. A single-center prospective observational study.

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., et al.

The Prostate , cilt.83, ss.792-800, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse.

von Eyben R., Hoffmann M. A., Kapp D. S., Soydal C., Uprimny C., Virgolini I., et al.

European urology oncology , cilt.5, ss.732-733, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis.

von Eyben R., Kapp D. S., Hoffmann M. A., Soydal C., Uprimny C., Virgolini I., et al.

Cancers , cilt.14, sa.21, 2022 (SCI-Expanded, Scopus)

30. SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management-the EANM perspective

Ovcaricek P. P., Kreissl M. C., Campenni A., de Keizer B., Tuncel M., Vrachimis A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.12, ss.3959-3963, 2022 (SCI-Expanded, Scopus)

31. Diagnostic Performance of(99)mTc-methoxy-isobutyl-isonitrile (MIBI) Imaging in Hypofunctioning Thyroid Nodules: A European Multicenter Study

Schenke S., Campenni A., Tuncel M., Piccardo A., Sager S., Crncic T. B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

32. FDG-PET/CT Imaging of Large Vessel Vasculitis

Kaya G., Tuncel M.

Acta Medica , cilt.53, ss.37-44, 2022 (Hakemli Dergi)

33. Cerebellar Hypermetabolism: An Alternative Marker for Diagnosis of Paraneoplastic Cerebellar Degeneration.

Arslan D., Ardıc F. S., Gultekin-Zaim O. B., Tuncel M., Kertmen N., Gocmen R., et al.

Neurologia (Barcelona, Spain) , 2022 (Hakemli Dergi)

34. To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.

Tuncel M., Vrachimis A., Campenni A., de Keizer B., Verburg F. A., Kreissl M. C., et al.

European journal of nuclear medicine and molecular imaging , cilt.49, sa.10, ss.3316-3319, 2022 (SCI-Expanded, Scopus)

35. Diagnostic Performance of Tc-99m-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study

Schenke S. A., Campenni A., TUNCEL M., Bottoni G., Sager S., Bogovic Crncic T., et al.

DIAGNOSTICS , cilt.12, sa.6, 2022 (SCI-Expanded, Scopus)

36. Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center

Suslu N. S., KATAR O., TUNCEL M.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.279, sa.3, ss.1549-1560, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Predictive Value of Dual-phase F-18-FDG PET/CT in the Assessment of Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer: A prospective Comparative Study with Dynamic Contrast-enhanced Magnetic Resonance Imaging

Kupik O., TUNCEL M., Kiratli P. O., GÜLSÜN AKPINAR M., Altundag K., DEMİRKAZIK F., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, ss.426-435, 2022 (ESCI, Scopus, TRDizin)

38. 18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study

Kupik O., TUNCEL M., AKSOY S., Kiratli P. O., GÜLSÜN AKPINAR M., Altundag K., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.3, ss.150-158, 2022 (SCI-Expanded, Scopus)

39. Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.

Mavi M. E., Tuncel M.

Clinical nuclear medicine , cilt.46, ss.1002-1003, 2021 (SCI-Expanded, Scopus)

40. 68Ga-DOTATATE PET/CT in Pituitary Carcinoma.

Kaya G., Soydas Turan B., Dagdelen S., Berker M., Tuncel M.

Clinical nuclear medicine , cilt.46, ss.996-998, 2021 (SCI-Expanded, Scopus)

41. A multicenter survey of current practices of Tc-99m-methoxy-isobutyl-isonitrile (MIBI) imaging for the diagnosis of thyroid nodules: more standardization is essential

Schenke S. A., Campenni A., TUNCEL M., Piccardo A., Sager S., Crncic T. B., et al.

CLINICAL AND TRANSLATIONAL IMAGING , cilt.9, sa.5, ss.413-422, 2021 (SCI-Expanded, Scopus)

42. Clinical parameters and nomograms for predicting lymphnode metastasis detected with 68Ga-PSMA-PET/CT

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.161, 2021 (SCI-Expanded, Scopus)

43. Clinical parameters and nomograms for predicting lymph node metastasis detected with ⁶⁸ Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy.

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

The Prostate , cilt.81, ss.648-656, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Predictive factors of tumor sink effect: Insights from Lu-177-Prostate-specific membrane antigen therapy

TUNCEL M., TELLİ T., ÇAĞLAR TUNCALI M., KARABULUT E.

ANNALS OF NUCLEAR MEDICINE , cilt.35, sa.5, ss.529-539, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection? Cerrahi doku yapıştırıcılar akciğer kanseri rezeksiyonu sonrası takip pozitron emisyon tomografisinde yanlış pozitifliğe neden olur mu?

Doğan R., Uysal S., Kumbasar U., Köksal D., Ancın B., Tuncel M.

Tuberkuloz ve Toraks , cilt.69, sa.1, ss.59-64, 2021 (ESCI, Scopus, TRDizin)

46. Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer

Karpuz M., Silindir-Gunay M., Ozer A. Y., Ozturk S. C., Yanik H., Tuncel M., et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.156, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Colonic Visualization of Tc-99m-DMSA Due to Enterovesical Fistula

TELLİ T., KAYA G., IŞIK Z., TUNCEL M.

CLINICAL NUCLEAR MEDICINE , cilt.46, sa.1, ss.66-68, 2021 (SCI-Expanded, Scopus)

48. Non-ultrasonographic and Non-radioiodine Imaging Techniques in Thyroid Cancer

TUNCEL M.

NUCLEAR MEDICINE SEMINARS , cilt.7, 2021 (Hakemli Dergi)

49. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?

Asi T., Tuncali M., Tuncel M., Alkanat N., Hazir B., Kösemehmetoğlu K., et al.

Urologic Oncology: Seminars and Original Investigations , cilt.38, sa.12, 2020 (SCI-Expanded, Scopus)

50. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT

ÇAĞLAR TUNCALI M., TUNCEL M., Yildiz E., KARABULUT E.

ANNALS OF NUCLEAR MEDICINE , cilt.34, sa.12, ss.932-941, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68Ga-PSMA-PET/CT in prostate cancer patients

Önal C., Özyiğit G., Oymak E., Güler O. C., Hürmüz P., Tilki B., et al.

International Journal Of Radiation Oncology Biology Physics , cilt.3, sa.108, ss.895, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients

Onal C., Ozyigit G., Cem G., Hurmuz P., Torun N., Tuncel M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.151, ss.222-227, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer.

Tuncel M., Tuncalı M., Telli T., Erman M.

Clinical nuclear medicine , cilt.45, ss.757-764, 2020 (SCI-Expanded, Scopus)

54. Clinical impact of <sup>68</sup>Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.

Tuncel M., Kılıçkap S., Süslü N.

Annals of nuclear medicine , cilt.34, ss.663-674, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement

Kupik O., Akin S., Tuncel M., Eren G., Türker A., Kars A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.41, sa.6, ss.540-549, 2020 (SCI-Expanded, Scopus)

56. Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature

YILMAZ M. T., GÜLTEKİN M., YALÇIN Ş., TUNCEL M., Gedikoglu G., YILDIZ F., et al.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY , cilt.25, sa.3, ss.331-335, 2020 (ESCI, Scopus)

57. Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature

GÜLTEKİN M., Esen C. S. B., AKGÖR U., SALMAN M. C., TUNCEL M., Ozmen M., et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY , cilt.12, sa.2, ss.175-180, 2020 (SCI-Expanded, Scopus)

58. Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment

Aydın K., Ersöz G., Tuncel M., Balcı C., Akın Ş., Çınar N., et al.

Turkish journal of medical sciences , cilt.49, ss.738-745, 2019 (SCI-Expanded, Scopus, TRDizin)

59. Radioguided occult lesion localization in patients with recurrent thyroid cancer.

Tuncel M., Süslü N.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery , cilt.276, ss.1757-1766, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Ga-68-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer

AKDEMİR E., TUNCEL M., AKYOL H. F., BİLEN C. Y., Baydar D. E., KARABULUT E., et al.

WORLD JOURNAL OF UROLOGY , cilt.37, sa.5, ss.813-821, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Radiolabeled, folate-conjugated liposomes as tumor imaging agents: Formulation and in vitro evaluation

Silindir-Gunay M., KARPUZ M., Ozturk N., Yekta Ozer A., ERDOĞAN S., TUNCEL M.

Journal of Drug Delivery Science and Technology , cilt.50, ss.321-328, 2019 (SCI-Expanded, Scopus)

62. Critical Role of Ga-68 DOTATATE PET-CT in a Patient with Neuroendocrine Tumor and Second Primary Cancer

TELLİ T., TUNCEL M., KILIÇKAP S.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.23, sa.1, ss.58-63, 2019 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

63. Value of post-therapy 177Lu-PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT Valor de las imágenes de 177Lu-PSMA post-terapia para una interpretación precisa de la respuesta a la terapia con PET/TC con 68Ga-PSMA

TUNCEL M., TELLİ T.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.2, ss.114-117, 2018 (SCI-Expanded, Scopus)

64. Effectiveness of Radioisotype Synoviectomy in Haemophilia Patients With High Titer Inhibitors

AYTAÇ S. A., Bajin I. Y., Altan I., TUNCEL M., ÇAĞLAR Ö., ÇETİN M., et al.

HAEMOPHILIA , cilt.23, ss.129-130, 2017 (SCI-Expanded, Scopus)

65. Thyroid stimulating hormone receptor Tiroid Stimulan Hormon Reseptörü

TUNCEL M.

Molecular Imaging and Radionuclide Therapy , cilt.26, ss.87-91, 2017 (Scopus, TRDizin)

66. Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma

OKUYUCU K., OZAYDLN S., Alagoz E., OZGUR G., INCE S., OYSUL F. G., et al.

Radiology and Oncology , cilt.50, sa.4, ss.360-369, 2016 (SCI-Expanded, Scopus)

67. Results of intraoperative gamma probe survey and frozen section in surgical treatment of parathyroid adenoma in children

SOYER T., KARNAK İ., TUNCEL M., EKİNCİ S., Andiran F., ÇİFTÇİ A. Ö., et al.

JOURNAL OF PEDIATRIC SURGERY , cilt.51, sa.9, ss.1492-1495, 2016 (SCI-Expanded, Scopus)

68. Symptomatic Adrenal Insufficiency due to Bilateral Adrenal Non-Hodgkin’s Lymphoma

AKIN Ş., Akın S., TUNCEL M., ERSÖZ G. N.

Turkish Journal of Endocrinology and Metabolism , cilt.20, ss.108-110, 2016 (Scopus, TRDizin)

69. Renal Function Assessment During Peptide Receptor Radionuclide Therapy

Erbas B., TUNCEL M.

SEMINARS IN NUCLEAR MEDICINE , cilt.46, sa.5, ss.462-478, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. Nuclear Medicine in Pediatric and Adolescent Tumors

Kiratli P. O., TUNCEL M., bar-sever Z.

SEMINARS IN NUCLEAR MEDICINE , cilt.46, sa.4, ss.308-323, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Comparison of wire-guided localization and radio-guided occult lesion localization in preoperative localization of nonpalpable breast lesions

Kanat N. B., TUNCEL M., Aksoy T., FIRAT A., DEMİRKAZIK F., Onat D., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.6, ss.1829-1837, 2016 (SCI-Expanded, Scopus, TRDizin)

72. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.

Tuncel M., Lay E., Caglar T.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.21, ss.1296-1306, 2016 (SCI-Expanded, Scopus)

73. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT

Silindir M., Erdoğan S., Özer A. Y., Doğan A. L., Tuncel M., Uğur Ö., et al.

JOURNAL OF LIPOSOME RESEARCH , cilt.23, sa.1, ss.20-27, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster

Özdemir D. M., Dağdelen S., Kıratlı P., Tuncel M., Erbas B., Erbas T.

MINERVA ENDOCRINOLOGICA , cilt.32, sa.3, ss.267-274, 2012 (SCI-Expanded, Scopus)

75. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster.

Ozdemir D., Dagdelen S., Kiratli P., Tuncel M., Erbas B., Erbas T.

Minerva endocrinologica , cilt.37, sa.3, ss.267-74, 2012 (SCI-Expanded, Scopus)

76. Osteopoikilosis: a major diagnostic problem solved by bone scintigraphy

TUNCEL M., Caner B.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.31, sa.2, ss.93-96, 2012 (SCI-Expanded, Scopus)

77. 99mTc-MDP uptake in thyroid nodule: contribution of SPECT-CT and ultrasonography.

Tuncel M., Akdemir E.

Revista espanola de medicina nuclear e imagen molecular , cilt.31, ss.49-50, 2012 (SCI-Expanded, Scopus)

78. SPECT-CT imaging of poliostotic fibrous dysplasia.

Tuncel M., Kiratli P., Gedikoglu G.

Revista espanola de medicina nuclear e imagen molecular , cilt.31, ss.47-8, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. The value of SPECT-CT in the calculation of post-operative FEV1 value: Preliminary results

TUNCEL M., Kiratli P. O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

80. Clinical Impact of SPECT-CT on Bone Scintigraphy in Oncology: Pattern Approach

TUNCEL M., ERGÜN E., Tuncali M. C.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

81. Gastroesophageal reflux scintigraphy: interpretation methods and inter-reader agreement.

Tuncel M., Kıratlı P., Aksoy T., Bozkurt M.

World journal of pediatrics : WJP , cilt.7, ss.245-9, 2011 (SCI-Expanded, Scopus)

82. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Arslan N., Tuncel M., Kuzhan O., Alagoz E., Budakoglu B., Ozet A., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.25, sa.6, ss.406-413, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

83. The value of SPECT-CT in the post I-131 ablation evaluation of patients with thyroid cancer

TUNCEL M., Vatankulu B., Caglar M.

JOURNAL OF NUCLEAR MEDICINE , cilt.52, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. Butterfly vertebra: a diagnostic pitfall on bone scintigraphy.

Tuncel M., Topbasi Z., Kiratli P.

Clinical nuclear medicine , cilt.35, ss.293-4, 2010 (SCI-Expanded, Scopus)

85. Simultaneous Anterior-Posterior Dynamic Renal Scintigraphy for the Evaluation of Congenital Abnormal Kidneys

ERGÜN E., TUNCEL M., BOZKURT M. F., Caner B.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.1, ss.155-161, 2009 (SCI-Expanded, Scopus)

86. The Clinical Features Of The Tall Cell Variant Of Papillary Thyroid Carcinoma

Alagoz E., Arslan N., Ilgan S., Karacalioglu A. O., Emer O., Ayan A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.35, 2008 (SCI-Expanded, Scopus)

87. Gated myocardial perfusion scintigraphy in children with myocarditis: can it be considered as an indicator of clinical outcome?

Kiratli P., Tuncel M., Ozkutlu S., Caglar M.

Nuclear medicine communications , cilt.29, ss.907-14, 2008 (SCI-Expanded, Scopus)

88. Gated MPS in Children with Myocarditis: Can it be Considered as an Indicator of Clinical Outcome?

Kiratli P., TUNCEL M., Caglar M., Ozkutlu S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.35, 2008 (SCI-Expanded, Scopus)

89. [C-11]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

Tuncel M., Souvatzoglou M., Herrman K., Stollfuss J., Schuster T., Weirich G., et al.

NUCLEAR MEDICINE AND BIOLOGY , cilt.35, sa.6, ss.689-695, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

90. Efficacy of 11C-Choline PET/CT for detection of recurrence in patients with rising PSA after radical prostatectomy

Treiber U., Souvatzoglou M., Tuncel M., Maurer T., Kuebler H., Zantl N., et al.

EUROPEAN UROLOGY SUPPLEMENTS , cilt.7, sa.3, ss.284, 2008 (SCI-Expanded)

91. The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Krause B. J., Souvatzoglou M., Tuncel M., Herrmann K., Buck A. K., Praus C., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.35, sa.1, ss.18-23, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. Diagnostic accuracy of F-18-FDG PET/CT in characterizing ovarian lesions

Tuncel M.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.28, sa.11, ss.879-880, 2007 (SCI-Expanded, Scopus)

93. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.

Tuncel M., Ozgen K.

Revista espanola de medicina nuclear , cilt.26, ss.226-9, 2007 (SCI-Expanded, Scopus)

94. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake

Tuncel M., Aydin D., Yaman E., Tazebay U. H., Guc D., Dogan A. L., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.22, sa.2, ss.281-288, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

95. The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake

Tuncel M., Aydin D., Cankaya E. Y., Tazebay U. H., Guc D., Dogan A. L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus)

96. The value of 11C-Choline PET/CT versus 11C-Choline PET in the evaluation of patients with prostate cancer with suspicion of bone metastases

Souvatzoglou M., Tuncel M., Herrman K., Stollfuss J., Schwaiger M., Krause B. J.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus)

97. How much CT do we need in C-11-Choline PET/CT in patients suffering from prostate cancer with suspicion of bone metastases?

Tuncel M., Souvatzoglou M., Herrman K., Stollfuss J., Schwaiger M., Krause B. J.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake

Tuncel M., Aydin D., Cankaya E. Y., Tazebay U. H., Guc D., Dogan A. L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus)

99. The influence of the PSA value on the sensitivity of C-11-Choline PET/CT in restaging patients with recurrent prostate cancer

Tuncel M., Souvatzoglou M., Herrmann K., Busch R., Stollfuss J., Schwaiger M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

100. Behcet disease with an intrapulmonary shunt.

Tuncel M., Kiratli P., Mahmoudian B.

Clinical nuclear medicine , cilt.31, ss.181-2, 2006 (SCI-Expanded, Scopus)

101. Value of hepatobiliary scintigraphy after type 1 choledochal cyst excision and Roux-en-y hepatojejunostomy

Tuncel M., Ergün E.

Clinical Nuclear Medicine , cilt.31, sa.2, ss.93-95, 2006 (SCI-Expanded, Scopus)

102. Scintigraphic imaging of radiolabelled drug delivery systems in rabbits with arthritis

Turker S., Erdogan S., Ozer Z., Ergun E., Tuncel M., Bilgili H., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.296, sa.1-2, ss.34-43, 2005 (SCI-Expanded, Scopus)

103. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer.

Caglar M., Tuncel M., Alpar R.

Annals of nuclear medicine , cilt.18, ss.479-82, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

104. Selected intra-arterial injection of Tc-99m MDP.

Mahmoudian B., Ozgen K., Tuncel M., Bozkurt F.

Revista espanola de medicina nuclear , cilt.23, ss.284-5, 2004 (SCI-Expanded, Scopus)

105. Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.

Caglar M., Tuncel M., Usubutun A.

Clinical nuclear medicine , cilt.28, ss.945-6, 2003 (SCI-Expanded, Scopus)

106. Gamut: soft tissue uptake of bone radiopharmaceuticals.

Tuncel M., Erbas B., Mahmoudian B.

Seminars in nuclear medicine , cilt.33, ss.334-7, 2003 (SCI-Expanded, Scopus)

107. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment

Caglar M., Tuncel M., Alpar R.

CLINICAL NUCLEAR MEDICINE , cilt.27, sa.11, ss.767-771, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.

Caglar M., Tuncel M.

Clinical nuclear medicine , cilt.27, ss.532-3, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. Osteoid osteoma of the rib detected on bone scintigraphy: importance of pattern recognition.

Tuncel M., Caglar M.

Clinical nuclear medicine , cilt.27, ss.216-7, 2002 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 49

1. An Extremely Rare MEN4 case with Multimodality Imaging

KODAZ O., Kaya G., TUNCEL M., Tuncali M. C.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

2. Imaging Armamentarium of Hyperparathyroidism; New Player FCH PET-CT-US

TUNCEL M., Kaya G., Caglar M., Kaynaroglu V., CENNET Ö., ÜNLÜTÜRK U., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

3. Radiolabelling of Gallium-68 DTPA and EDTA used for Kidney Imaging

- Molaei A., SARCAN BOZKIR E. T., ERDOĞAN S., TUNCEL M.

International Multidisciplinary Symposium on Drug Research and Development (DRD) 2023, İzmir, Türkiye, 04 Mayıs 2023, (Özet Bildiri)

4. Clinical Significance of Bayesian penalized-likelihood and Motion Correction PET Reconstruction Algorithms

Kaya G., Pala H., Tuncel M., Uğur Ö.

Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain, Barcelona, İspanya, 15 - 19 Ekim 2022, ss.163, (Özet Bildiri)

5. KHDAK Olgularında İnsan Epididim Proteini (HE4) Düzeyi ile PET Parametreleri Arasındaki Korelasyonun Değerlendirilmesi

YILMAZ Y., ÖZERCAN M. M., ANCIN B., DİKMEN Z. G., KILIÇKAP S., ÇAĞLAR TUNCALI M., et al.

11.Ulusal Göğüs Cerrahisi Kongresi, Antalya, Türkiye, 24 - 27 Ekim 2021, (Özet Bildiri)

6. Do ultrasound elastography and thyroid imaging reporting and data systems correctly classify hyperfunctioning nodules on thyroid scintigraphy?

Tuncel M., Turan B. S., Isik Z.

cilt.48, (Özet Bildiri)

7. Factors that could predict tumour sink effect: Experience with Lu177 Prostatespecific membrane antigen therapy

Tuncel M., Telli T., Tuncali M., Karabulut E.

cilt.48, (Özet Bildiri)

8. Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri) Sürdürülebilir Kalkınma

9. Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients

ÖNAL H. C., ÖZYİĞİT G., Oymak E., GÜLER O. C., HÜRMÜZ P., TİLKİ B., et al.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 25 Ekim - 28 Aralık 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Clinical Impact Of [Ga-68]Ga-DOTA-TATE Imaging In Patients With Medullary Thyroid Cancer

Tuncel M., Kilickap S., Suslu N.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Efficacy of Lu-177-PSMA-617 Therapy in Metastatic Castration-resistant Prostate Cancer Patients, A Single-Center Experience

Telli T., Tuncel M., Caglar M.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Is It Safe Enough to Follow-up Patients Only with Post-therapy Whole-body Scan After PRRT?

Telli T., Tuncel M., Kiratli P. O.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri)

13. Predictors of Intertumoral Heterogeneity of F-18-FDG and Ga-68-PSMA Uptake in Patients with Prostate Cancer

Telli T., Tuncel M., Caglar M.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 Ekim 2020, cilt.47, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Akciğer Kanseri nedeniyle rezeksiyon uygulanan hastalarda doku yapıştırıcı kullanımı yalancı PET pozitifliğine neden oluyor mu?

DOĞAN R., UYSAL S., KÖKSAL D., KUMBASAR U., TUNCEL M.

Girişimsel Onkoloji Toplantısı – Multidisipliner Tedavi Yaklaşımı, Ankara, Türkiye, 13 - 15 Aralık 2019, (Özet Bildiri)

15. In vitro and In vivo Diagnostic and Therapeutic Evaluation of Folate-Targeted, Paclitaxel and Vinorelbine Encapsulated Theranostıc Liposomes in Non-Small Cell Lung Cancer

Karpuz M., Silindir Günay M., Öztürk S. C., Yanık H., Tuncel M., Esendağlı G., et al.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Türkiye, 13 - 16 Ekim 2019, ss.90-91, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

16. How accurate is serum thyroglobulin measurement in patients with differentiated thyroid cancer?

TUNCEL M., TELLİ T., Tuncali M. C.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri) Sürdürülebilir Kalkınma

17. The Role of (68)ga-PSMA-PET/CT in Pelvic FIELD Delineation in Prostate Cancer Patients with Pelvic Lymph Node Metastasis

Onal C., HÜRMÜZ P., Torun N., TUNCEL M., Guler O. C., Reyhan M., et al.

61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, Amerika Birleşik Devletleri, 15 - 18 Eylül 2019, cilt.105, (Özet Bildiri)

18. Integration of (68)ga-PSMA-PET/BT in Radiation Therapy Planning for Prostate Cancer Patients: A Multi-Institutional Analysis

Onal C., Torun N., HÜRMÜZ P., Guler O. C., TUNCEL M., Yildirim B. A., et al.

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 21 - 24 Ekim 2018, cilt.102, (Özet Bildiri)

19. Slowly progressive disease a new therapy response criteria? Lessons from tyrosine kinase inhibitor therapy

TUNCEL M.

88th Annual Meeting of the American Thyroid Association, Washington, Kiribati, 03 Ekim 2018 - 07 Ekim 2108, cilt.28, (Özet Bildiri)

20. The Role of FDG PET/CT Detecting Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients

KUPIK O., Akin S., TUNCEL M., TÜRKER A., Kars A., Erbas B.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)

21. Yavaş büyüyen soliter pulmoner nodül: Adenoleiomyomatöz Hamartom

BABAOĞLU E., SARINÇ ULAŞLI S., ÖNDER S. Ç., TUNCEL M., KÖKSAL D.

Ulusal Akciğer Sağlığı KOngresi, Türkiye, 14 - 18 Mart 2018, (Özet Bildiri)

22. FDG PET-CT parameters in the therapy evaluation of patients with Hodgkin's lymphoma

TUNCEL M., Kutluk T. M., Kiratli P. O., AYDIN B., Erbas B., AKYÜZ C.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

23. Tuncel M Kurucu N Kıratlı PÖ Erbaş B Akyüz C Clinical Impact of FDG PET CT in pediatric soft tissue sarcoma Eur J Nucl Med Mol Imaging

TUNCEL M., KURUCU N., ÖZGEN KIRATLI M. P., ERBAŞ H. B., AKYÜZ C.

Annual Congress of the European Association of the Nucleer Medicine, Hamburg, Almanya, 10 - 14 Ekim 2015, cilt.42, ss.206, (Özet Bildiri)